<DOC>
	<DOCNO>NCT01612312</DOCNO>
	<brief_summary>Whereas thrombus aspiration patient ST-elevation myocardial infarction ( STEMI ) recommend current guideline , insufficient data unequivocally support thrombectomy patient non-STEMI ( NSTEMI ) . The Thrombus Aspiration ThrOmbus contain culpRiT lesion Non-ST-Elevation Myocardial Infarction ( TATORT-NSTEMI ) trial 400 patient , prospective , control , multicenter , randomize , open-label trial . The hypothesis background early revascularization , adjunctive thrombectomy comparison conventional percutaneous coronary intervention ( PCI ) alone lead less microvascular obstruction ( MO ) assess cardiac magnetic resonance imaging ( CMR ) patient NSTEMI . Patients randomize 1:1 fashion one two treatment arm . The primary endpoint extent MO assess CMR . Secondary endpoint include infarct size myocardial salvage assess CMR , enzymatic infarct size well angiographic parameter , Thrombolysis Myocardial Infarction-flow post-PCI myocardial blush grade . Furthermore , clinical endpoint include death , myocardial reinfarction , target vessel revascularization new congestive heart failure record 6 12 month . Safety assess bleed stroke . In summary , TATORT-NSTEMI trial design test hypothesis thrombectomy improve myocardial perfusion patient NSTEMI relevant thrombus burden culprit vessel reperfused early PCI .</brief_summary>
	<brief_title>Thrombus Aspiration ThrOmbus Containing culpRiT Lesions Non-ST-Elevation Myocardial Infarction ( TATORT-NSTEMI )</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Thrombosis</mesh_term>
	<criteria>ischemic symptom angina pectoris &gt; 20 minute occurrence last symptom &lt; 72 h randomization cardiac troponin T I level 99th percentile culprit lesion contain thrombus ( TIMIthrombus grade 25 within lesion ) intend early PCI cardiogenic shock STEMI identifiable culprit lesion TIMIthrombus grade &lt; 2 coronary morphology ineligible thrombectomy ( e.g . tortuous vessel , severe calcification ) indication acute bypass surgery age &lt; 18 &gt; 90 year contraindication treatment heparin , aspirin thienopyridines pregnancy current participation another clinical study comorbidity limit life expectancy &lt; 6 month contraindication CMR study entry</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Non-ST-elevation myocardial infarction</keyword>
	<keyword>thrombectomy</keyword>
	<keyword>magnetic resonance imaging</keyword>
	<keyword>microvascular obstruction</keyword>
</DOC>